Andrew Wey

Andrew Wey

Auto-generated profile, based on publicly available information

Andrew Wey

Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, Minnesota, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2022 in American Journal of Transplantation
Verified
Journal Article
Open access
MVMaryam Valapour
Maryam Valapour
CLCarli J. Lehr
Carli J. Lehr
AWAndrew Wey
Andrew Wey
MSMelissa A. Skeans
Melissa A. Skeans
JMJonathan Miller
Jonathan Miller
ELErika D. Lease
Erika D. Lease
Efforts are underway to transition the current lung allocation system to a continuous distribution framework whereby multiple factors are simultaneously combined into a Composite Allocation Score (CAS) to prioritize candidates for lung transplant. The purpose of this study was to compare discrete CAS scenarios with the current concentric circle-based allocation system to assess their potential effects on the US lung transplantation system using the Scientific Registry of Transplant Recipients' thoracic simulated allocation model. Six alternative CAS scenarios were compared over 10 simulation runs using data from individuals on the lung transplant waiting list from January 1, 2018, through December 31, 2019. Outcome measures were transplant rate, count, waitlist deaths, posttransplant deaths within 2 years, donor-to-recipient distance, and percentage of organs predicted to have flown. Across scenarios, waitlist deaths decreased by 36% to 47%, with larger decreases in deaths at lower placement efficiency weight and higher weighting of the waitlist outcomes. When waitlist outcomes were equally weighted to posttransplant outcomes, more transplants occurred in individuals with the highest expected posttransplant survival. All CAS scenarios led to improved overall measures of equity compared with the current Lung Allocation Score system, including reduced waitlist deaths, and resulted in similar posttransplant survival.

5 September 2021 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
AWAndrew Wey
Andrew Wey
SNSamantha Noreen
Samantha Noreen
SGSommer Gentry
Sommer Gentry
MCMatt Cafarella
Matt Cafarella
JTJames Trotter
James Trotter
JSJon Snyder
Jon Snyder

1 April 2018 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
AWAndrew Wey
Andrew Wey
NSNicholas Salkowski
Nicholas Salkowski
WKWalter K. Kremers
Walter K. Kremers
CSCory R. Schaffhausen
Cory R. Schaffhausen
BKBertram L. Kasiske
Bertram L. Kasiske
JSJon J. Snyder
Jon J. Snyder
We developed a kidney offer acceptance decision tool to predict the probability of graft survival and patient survival for first-time kidney-alone candidates after an offer is accepted or declined, and we characterized the effect of restricting the donor pool with a maximum acceptable kidney donor profile index (KDPI). For accepted offers, Cox proportional hazards models estimated these probabilities using transplanted kidneys. For declined offers, these probabilities were estimated by considering the experience of similar candidates who declined offers and the probability that declining would lead to these outcomes. We randomly selected 5000 declined offers and estimated these probabilities 3 years post-offer had the offers been accepted or declined. Predicted outcomes for declined offers were well calibrated (< 3% error) with good predictive accuracy (AUC: graft survival, 0.69; patient survival, 0.69). Had the offers been accepted, the probabilities of graft survival and patient survival were typically higher. However, these advantages attenuated or disappeared with higher KDPI, candidate priority, and local donor supply. Donor pool restrictions were associated with worse 3-year outcomes, especially for candidates with high allocation priority. The kidney offer acceptance decision tool could inform offer acceptance by characterizing the potential risk-benefit tradeoff associated with accepting or declining an offer.

23 February 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
JMJonathan Miller
Jonathan Miller
AWAndrew Wey
Andrew Wey
DMDonald Musgrove
Donald Musgrove
YAYoon Son Ahn
Yoon Son Ahn
AHAllyson Hart
Allyson Hart
JSJon J. Snyder
Jon J. Snyder
We examined the effects of COVID‐19 on solid organ waiting list mortality in the United States and compared effects across patient demographics (e.g., race, age, and sex) and donation service areas. Three separate piecewise exponential survival models estimated for each solid organ the overall, demographic‐specific, and donation service area‐specific differences in the hazard of waitlist mortality before and after the national emergency declaration on March 13, 2020. Kidney waiting list mortality was higher after than before the national emergency (adjusted hazard ratio [aHR], 1.37; 95% CI, 1.23–1.52). The hazard of waitlist mortality was not significantly different before and after COVID‐19 for liver (aHR, 0.94), pancreas (aHR, 1.01), lung (aHR, 1.00), and heart (aHR, 0.94). Kidney candidates had notable variability in differences across donation service areas (aHRs, New York City, 2.52; New Jersey, 1.84; and Michigan, 1.56). The only demographic group with increased waiting list mortality were Blacks versus Whites (aHR, 1.41; 95% CI, 1.07–1.86) for kidney candidates. The first 10 weeks after the declaration of a national emergency had a heterogeneous effect on waitlist mortality rate, varying by geography and ethnicity. This heterogeneity will complicate comparisons of transplant program performance during COVID‐19.

11 March 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
JSJon J. Snyder
Jon J. Snyder
DMDonald Musgrove
Donald Musgrove
DZDavid Zaun
David Zaun
AWAndrew Wey
Andrew Wey
NSNicholas Salkowski
Nicholas Salkowski
BKBertram L. Kasiske
Bertram L. Kasiske
On December 23, 2019, the US Centers for Medicare and Medicaid Services proposed two new standards that organ procurement organizations (OPOs) must meet for recertification. An OPO's organ donation rate (deceased donors/potential donors) and organ transplantation rate (organs transplanted/potential donors) must not fall significantly below the 75th percentile for rates among all OPOs. We examined how OPOs would have fared under the proposed performance standards in 2016‐2017. Data on donors and transplants were from the Organ Procurement and Transplantation Network; donor potential was estimated from Detailed Multiple Cause of Death data collected by the Centers for Disease Control and Prevention. In 2017, 31 (53%) OPOs failed to meet the proposed donation rate standard, 36 (62%) failed to meet the proposed organ transplantation rate standard, and 37 (64%) failed at least one standard. We found that adjusting for age, race, and Hispanic ethnicity altered the evaluation: eight OPOs changed their pass/fail status for the donation rate and five for the proposed organ transplantation rate standard. We conclude that the proposed new standards may result in over half of OPOs facing decertification, and risk adjustment suggests that underlying characteristics of deaths vary regionally such that decertification decisions may be affected.

13 June 2017 in Health Services Research
Verified
Journal Article
Closed access
PDF file
AWAndrew Wey
Andrew Wey
NSNicholas Salkowski
Nicholas Salkowski
BKBertram L. Kasiske
Bertram L. Kasiske
AIAjay K. Israni
Ajay K. Israni
JSJon J. Snyder
Jon J. Snyder